Du, S.* ; Wisskirchen, K.* ; Zhang, K.* ; Protzer, U.
Correspondence on Editorial regarding "Genetically modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting".
Clin. Mol. Hepatol. 31, e44-e47 (2024)
Wan, X.* ; Wisskirchen, K.* ; Jin, T.* ; Yang, L.* ; Wang, X.* ; Wu, X.* ; Liu, F.* ; Wu, Y.* ; Ma, C.* ; Pang, Y.* ; Li, Q.* ; Zhang, K.* ; Protzer, U. ; Du, S.*
Genetically redirected HBV-specific T cells target HBsAg-positive hepatocytes and primary lesions in HBV-associated HCC.
Clin. Mol. Hepatol. 30, 735-755 (2024)